|
|
Ambien (Zolpidem tartrate)
|
 |
Central nervous system agent
|
 |
Sedatives and hypnotics, nonbarbiturate
|
 |
Zolpidem tartrate is indicated for the short-term treatment of insomnia. Hypnotics should generally be limited to 7 to 10 days of use; and re-evaluation of the patient is recommended if they are to be taken for more than 2 to 3 weeks.
|
 |
Adults: 10 mg/day immediately before bedtime. Maximum 10 mg/day. Children less that 18 years of age: Not recommended.
|
 |
Category B
|
 |
Dizziness, drowsiness, "drugged feeling," headache, confusion, and hiccups. Do not use for benzodiazepine or ethanol withdrawal.
|
Pregnancy Risk Categories defined:
A: Studies in pregnant women failed to show a risk to the fetus in the first
trimester - with no evidence of risk in the later trimesters.
B: Animals studies indicate no adverse effect to the fetus, but there are no adequate,
clinical studies in pregnant women.
C: Animal studies have shown an adverse effect on the fetus, but there are no adequate,
clinical studies in humans. Despite potential risks, the drug may be useful in pregnant
women.
D: There is evidence of risk to the human fetus, but the potential benefits of use in
pregnant women may be acceptable, despite potential risks.
X: Studies in animals or humans show fetal abnormalities, or adverse reaction reports
indicate evidence of fetal risk. Warning: the risks involved clearly outweigh any
potential benefit from using the drug in pregnant women, regardless of trimester.
NR: Not rated (i.e., no information available at this time as to the potential
risks or benefits).
|
| | |
If you want your friend to read or know about this article, Click here
 |
|
|
